{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:07:22Z","timestamp":1789020442665,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation Project of Hainan Province under Grant","award":["821MS0776"],"award-info":[{"award-number":["821MS0776"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04272-8","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:45:40Z","timestamp":1789019140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alpinia Oxyphylla-Shenqi Siwu Decoction protects against high glucose-induced retinal pigment epithelial cell injury involving the PI3K\/AKT\/mTOR pathway"],"prefix":"10.1007","volume":"46","author":[{"given":"Weiling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"issue":"1608580","key":"4272_CR1","first-page":"1","volume":"13","author":"LS Hu","year":"2025","unstructured":"Hu LS, Wang J, Zhang HM, Huang HY (2025) Automated detection of diabetic retinopathy lesions in ultra-widefield fundus images using an attention-augmented YOLOv8 framework. Front Cell Dev Biol 13(1608580):1\u201312","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"4272_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","volume":"14","author":"I Genitsaridi","year":"2026","unstructured":"Genitsaridi I, Salpea P, Salim A, Sajjadi SF, Tomic D, James S et al (2026) 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol 14(2):149\u2013156","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"4272_CR3","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N et al (2021) Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 128(11):1580\u20131591","journal-title":"Ophthalmology"},{"issue":"6","key":"4272_CR4","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/ijms19061816","volume":"19","author":"W Wang","year":"2018","unstructured":"Wang W, Lo ACY (2018) Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci 19(6):1816\u20131833","journal-title":"Int J Mol Sci"},{"issue":"19","key":"4272_CR5","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","volume":"113","author":"EH Sohn","year":"2016","unstructured":"Sohn EH, van Dijk HW, Jiao C, Kok PH, Jeong W, Demirkaya N et al (2016) Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A 113(19):E2655\u2013E2664","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4272_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40662-021-00239-1","volume":"8","author":"S Nian","year":"2021","unstructured":"Nian S, Lo ACY, Mi Y, Ren K, Yang D (2021) Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutic targets. Eye Vis (Lond) 8(1):15\u201334","journal-title":"Eye Vis (Lond)"},{"issue":"5","key":"4272_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2174\/0115701611272737240426050930","volume":"22","author":"A Callan","year":"2024","unstructured":"Callan A, Jha S, Valdez L, Tsin A (2024) Cellular and molecular mechanisms of neuronal degeneration in early-stage diabetic retinopathy. Curr Vasc Pharmacol 22(5):301\u2013315","journal-title":"Curr Vasc Pharmacol"},{"issue":"102967","key":"4272_CR8","first-page":"1","volume":"68","author":"EW B\u00f6hm","year":"2023","unstructured":"B\u00f6hm EW, Buonfiglio F, Voigt AM, Bachmann P, Safi T, Pfeiffer N et al (2023) Oxidative stress in the eye and its role in the pathophysiology of ocular diseases. Redox Biol 68(102967):1\u201337","journal-title":"Redox Biol"},{"issue":"8","key":"4272_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox12081649","volume":"12","author":"CD Haydinger","year":"2023","unstructured":"Haydinger CD, Oliver GF, Ashander LM, Smith JR (2023) Oxidative stress and its regulation in diabetic retinopathy. Antioxidants 12(8):1\u201325","journal-title":"Antioxidants"},{"issue":"4","key":"4272_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3892\/mmr.2023.13072","volume":"28","author":"M Li","year":"2023","unstructured":"Li M, Tian M, Wang Y, Ma H, Zhou Y, Jiang X et al (2023) Updates on RPE cell damage in diabetic retinopathy (review). Mol Med Rep 28(4):185","journal-title":"Mol Med Rep"},{"key":"4272_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/582060","volume":"582060","author":"F Semeraro","year":"2015","unstructured":"Semeraro F, Cancarini A, dell\u2019Omo R, Rezzola S, Romano MR, Costagliola C (2015) Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res 582060:1\u201316","journal-title":"J Diabetes Res"},{"issue":"3","key":"4272_CR12","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3390\/ijms24032927","volume":"24","author":"T Oshitari","year":"2023","unstructured":"Oshitari T (2023) Advanced glycation end-products and diabetic neuropathy of the retina. Int J Mol Sci 24(3):2927\u20132945","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4272_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41420-023-01717-2","volume":"9","author":"J Li","year":"2023","unstructured":"Li J, Chen K, Li X, Zhang X, Zhang L, Yang Q et al (2023) Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy. Cell Death Discov 9(1):418\u2013433","journal-title":"Cell Death Discov"},{"issue":"1","key":"4272_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, Kim MJ, Kumar A, Lee HW, Yang Y, Kim Y (2025) Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Ther 10(1):170\u2013214","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"4272_CR15","first-page":"1","volume":"7","author":"G Maugeri","year":"2021","unstructured":"Maugeri G, Bucolo C, Drago F, Rossi S, Di Rosa M, Imbesi R et al (2021) Attenuation of high glucose-induced damage in RPE cells through p38 MAPK signaling pathway inhibition. Front Pharmacol 7(12):1\u20139","journal-title":"Front Pharmacol"},{"key":"4272_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173690","volume":"891","author":"TL Sun","year":"2021","unstructured":"Sun TL, Li WQ, Tong XL, Liu XY, Zhou WH (2021) Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN\/AKT\/mTOR pathway. Eur J Pharmacol 891:173690","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"4272_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26114992","volume":"26","author":"A Callan","year":"2025","unstructured":"Callan A, Heckman J, Tah G, Lopez S, Valdez L, Tsin A (2025) VEGF in diabetic retinopathy and age-related macular degeneration. Int J Mol Sci 26(11):1\u201314","journal-title":"Int J Mol Sci"},{"issue":"23","key":"4272_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/PCGV5709","volume":"29","author":"M Simmonds","year":"2024","unstructured":"Simmonds M, Llewellyn A, Walker R, Fulbright H, Walton M, Hodgson R et al (2024) Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis. Health Technol Assess 29(23):1\u201371","journal-title":"Health Technol Assess"},{"issue":"14","key":"4272_CR19","first-page":"1","volume":"16","author":"L Bianco","year":"2022","unstructured":"Bianco L, Arrigo A, Aragona E, Antropoli A, Berni A, Saladino A et al (2022) Neuroinflammation and neurodegeneration in diabetic retinopathy. Front Aging Neurosci 16(14):1\u201317","journal-title":"Front Aging Neurosci"},{"issue":"1416403","key":"4272_CR20","first-page":"1","volume":"15","author":"W Li","year":"2024","unstructured":"Li W, Liu X, Liu Z, Xing Q, Liu R, Wu Q et al (2024) The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review. Front Pharmacol 15(1416403):1\u201314","journal-title":"Front Pharmacol"},{"issue":"1","key":"4272_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s10792-025-03649-5","volume":"45","author":"X Rong","year":"2025","unstructured":"Rong X, Jiang Y, Qi M, Gao W, Rao Y (2025) SIGLEC1 ubiquitination and degradation induced by MARCHF3 protects ARPE19 retinal cells from high glucose-induced oxidative stress, inflammation, and apoptosis. Int Ophthalmol 45(1):298","journal-title":"Int Ophthalmol"},{"issue":"3","key":"4272_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659\u2013661","journal-title":"FASEB J"},{"issue":"6","key":"4272_CR23","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3892\/ijmm.2016.2768","volume":"38","author":"D Che","year":"2016","unstructured":"Che D, Zhou T, Lan Y, Xie J, Gong H, Li C et al (2016) High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells. Int J Mol Med 38(6):1815\u20131822","journal-title":"Int J Mol Med"},{"key":"4272_CR24","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13375","volume":"10","author":"D Zhu","year":"2022","unstructured":"Zhu D, Zou W, Cao X, Xu W, Lu Z, Zhu Y et al (2022) Ferulic acid attenuates high glucose-induced apoptosis in retinal pigment epithelium cells and protects retina in db\/db mice. PeerJ 10:e13375","journal-title":"PeerJ"},{"issue":"3","key":"4272_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5603\/fhc.107923","volume":"63","author":"Y Sui","year":"2025","unstructured":"Sui Y, Zhang C, Jiang B, Li W, Wang S (2025) Tectochrysin alleviates high-glucose-induced retinal pigment epithelial cell injury through Nrf2\/HO-1 activation. Folia Histochem Cytobiol 63(3):134\u2013141","journal-title":"Folia Histochem Cytobiol"},{"key":"4272_CR26","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.2147\/IJN.S219670","volume":"14","author":"WQ Li","year":"2019","unstructured":"Li WQ, Wu JY, Xiang DX, Luo SL, Hu XB, Tang TT et al (2019) Micelles loaded with puerarin and modified with triphenylphosphonium cation possess mitochondrial targeting and demonstrate enhanced protective effect against isoprenaline-induced H9c2 cells apoptosis. Int J Nanomedicine 14:8345\u20138360","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"4272_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/gtc.70036","volume":"30","author":"T Iwagawa","year":"2025","unstructured":"Iwagawa T, Inokuchi Y, Saita K, Soeda T, Usui-Ouchi A, Aihara M et al (2025) Effects of VEGFA and ANGPT2 antibodies on the activation of microglia in the early stages of streptozotocin-induced pathogenesis of diabetic retinopathy. Genes Cells 30(4):e70036","journal-title":"Genes Cells"},{"issue":"977971","key":"4272_CR28","first-page":"1","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Zhang J, He R, Su X, Li Z, Xie X (2022) Effect of Chinese herbal compounds on ocular fundus signs and vision in conventional treated-persons with non-proliferative diabetic retinopathy: a systematic review and meta-analysis. Front Endocrinol 13(977971):1\u201314","journal-title":"Front Endocrinol"},{"issue":"1","key":"4272_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/13813455.2020.1797101","volume":"129","author":"F Han","year":"2023","unstructured":"Han F, Zhang J, Li K, Wang W, Dai D (2023) Triptolide protects human retinal pigment epithelial ARPE-19 cells against high glucose-induced cell injury by regulation of miR-29b\/PTEN. Arch Physiol Biochem 129(1):54\u201360","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"4272_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/cells12020300","volume":"12","author":"RA Kowluru","year":"2023","unstructured":"Kowluru RA (2023) Cross talks between oxidative stress, inflammation and epigenetics in diabetic retinopathy. Cells 12(2):300\u2013314","journal-title":"Cells"},{"issue":"13","key":"4272_CR31","first-page":"1","volume":"13","author":"T Yue","year":"2022","unstructured":"Yue T, Shi Y, Luo S, Weng J, Wu Y, Zheng X (2022) The role of inflammation in immune system of diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Front Immunol 13(13):1\u201316","journal-title":"Front Immunol"},{"issue":"1","key":"4272_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295813","volume":"19","author":"R Guan","year":"2024","unstructured":"Guan R, Kang Z, Li L, Yan X, Gao T (2024) PIK3CA regulates development of diabetes retinopathy through the PI3K\/Akt\/mTOR pathway. PLoS ONE 19(1):e0295813","journal-title":"PLoS ONE"},{"issue":"1571576","key":"4272_CR33","first-page":"1","volume":"16","author":"W He","year":"2025","unstructured":"He W, Tang P, Lv H (2025) Targeting oxidative stress in diabetic retinopathy: mechanisms, pathology, and novel treatment approaches. Front Immunol 16(1571576):1\u201316","journal-title":"Front Immunol"},{"issue":"973856","key":"4272_CR34","first-page":"1","volume":"9","author":"F Casciano","year":"2022","unstructured":"Casciano F, Zauli E, Rimondi E, Mura M, Previati M, Busin M et al (2022) The role of the mTOR pathway in diabetic retinopathy. Front Med 9(973856):1\u201316","journal-title":"Front Med"},{"issue":"811897","key":"4272_CR35","first-page":"1","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Yang GY, Sun HY, Meng T, Cheng CC, Zhao HP et al (2021) Dioscin reduces vascular damage in the retina of db\/db mice by inhibiting the VEGFA signaling pathway. Front Pharmacol 12(811897):1\u201310","journal-title":"Front Pharmacol"},{"issue":"1","key":"4272_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00011-021-01518-2","volume":"71","author":"J Li","year":"2022","unstructured":"Li J, Lu X, Wei L, Ye D, Lin J, Tang X et al (2022) PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1\u03b1\/VEGF pathway. Inflamm Res 71(1):69\u201379","journal-title":"Inflamm Res"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04272-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04272-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04272-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:45:43Z","timestamp":1789019143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04272-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4272"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04272-8","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"3 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"389"}}